Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases

Abstract

[1]  G. Ghiggeri,et al.  Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment , 2023, Frontiers in immunology.

[2]  B. Rovin,et al.  Natural Antibody and Complement Activation Characterize Patients with Idiopathic Nephrotic Syndrome. , 2021, American journal of physiology. Renal physiology.

[3]  M. Schnitzler,et al.  Immunosuppression Considerations for Older Kidney Transplant Recipients , 2021, Current Transplantation Reports.

[4]  J. Myers,et al.  Association of physical function and performance with peak VO2 in elderly patients with end stage kidney disease , 2021, Aging Clinical and Experimental Research.

[5]  C. McCulloch,et al.  Sex Disparity in Deceased-Donor Kidney Transplant Access by Cause of Kidney Disease. , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[6]  M. Stedman,et al.  Toward telemedicine‐compatible physical functioning assessments in kidney transplant candidates , 2020, Clinical transplantation.

[7]  J. Hogan,et al.  A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome , 2020, Pediatric Nephrology.

[8]  M. Stedman,et al.  Physical Performance Testing in Kidney Transplant Candidates at the Top of the Waitlist. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  K. Khush,et al.  To kidney or not to kidney: Applying lessons learned from the simultaneous liver‐kidney transplant policy to simultaneous heart‐kidney transplantation , 2020, Clinical transplantation.

[10]  K. Johansen,et al.  An overview of frailty in kidney transplantation: measurement, management and future considerations. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  W. Kim,et al.  Defining a Willingness-to-transplant Threshold in an Era of Organ Scarcity: Simultaneous Liver–kidney Transplant as a Case Example , 2020, Transplantation.

[12]  K. Lentine,et al.  Implications of Frailty for Peritransplant Outcomes in Kidney Transplant Recipients , 2019, Current Transplantation Reports.

[13]  A. Bagga,et al.  Management of steroid-resistant nephrotic syndrome in children and adolescents. , 2018, The Lancet. Child & adolescent health.

[14]  Andrew A. Li,et al.  Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era , 2018, Diseases.

[15]  R. Parekh,et al.  Idiopathic nephrotic syndrome in children , 2018, The Lancet.

[16]  Donghee Kim,et al.  Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States , 2017, Transplantation.

[17]  Ming-hui Zhao,et al.  Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[18]  P. Ravani,et al.  Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry , 2016, Transplantation.

[19]  C. Lenihan,et al.  The consequences of chronic kidney disease mislabeling in living kidney donors. , 2014, Mayo Clinic proceedings.

[20]  Jane C. Tan,et al.  A new clinical prediction tool for 5-year kidney transplant outcome. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  N. Kambham,et al.  Acute transplant glomerulopathy with monocyte rich infiltrate. , 2013, Transplant immunology.

[22]  D. Gipson,et al.  Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO , 2013, Pediatric Nephrology.

[23]  A. Edefonti,et al.  Rituximab in children with resistant idiopathic nephrotic syndrome. , 2012, Journal of the American Society of Nephrology : JASN.

[24]  B. Daniel,et al.  Multiple renal arteries and non-contrast magnetic resonance angiography in transplant renal artery stenosis , 2012, Clinical kidney journal.

[25]  S. Busque,et al.  Living donor evaluation and exclusion: the Stanford experience , 2011, Clinical transplantation.

[26]  G. Chertow,et al.  Cautious optimism concerning long-term safety of kidney donation. , 2009, The New England journal of medicine.

[27]  P. Tummala,et al.  Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia. , 2006, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[28]  H. Valantine,et al.  Validation of a screening protocol for identifying low‐risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation , 2006, Clinical transplantation.

[29]  S. Busque,et al.  Preoperative renal volumes as a predictor of graft function in living donor transplantation. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  E. Alfrey,et al.  Dual-Kidney Transplantation with Organs from Expanded Criteria Donors: A Long-Term Follow-Up , 2004, Transplantation.

[31]  H. Yeh,et al.  Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: cyclic AMP as intracellular intermediary , 1996, Neuroscience.